Pharvaris
Jerry Langlois is an experienced quality assurance professional with a strong background in quality systems and operations within the pharmaceutical industry. Currently serving as Director and QA QMS Lead at Pharvaris since February 2024, Langlois previously held roles such as Associate Director of Quality Systems at Omega Therapeutics and Associate Director of GMP Quality Assurance Operations at EQRx. Langlois's extensive career includes positions at Agios Pharmaceuticals, Merrimack, Johnson Matthey Pharma Services, Bristol-Myers Squibb, and Wyeth Biopharma, demonstrating a robust expertise in quality control and assurance. Langlois holds a Bachelor of Science degree in Medical Technology from the University of Massachusetts Lowell, earned between 1992 and 1998.
This person is not in any teams
This person is not in any offices
Pharvaris
2 followers
Pharvaris is a preclinical stage company focused on bringing an oral bradykinin B2 receptor antagonist to patients for use as an alternative to injected therapies for hereditary angioedema (HAE) and other B2 receptor-mediated indications. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically proven therapeutic target.